Trial site
Severance Hospital Yonsei University
- 11running trials
- 9closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Metastatic breast cancer3 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Liver and biliary tract cancer2 trials
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- and 10 more
- Phase
- Phase 27 trials
- Phase 1/25 trials
- Phase 35 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Recruiting5 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Daiichi Sankyo3 trials
- EMD Serono Research & Development Institute, Inc.3 trials
- Yuhan Corporation2 trials
- ALX Oncology Inc.1 trial
- Bold Therapeutics, Inc.1 trial
- and 10 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
Recruiting
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Childhood cancers2 recruiting
- Colorectal cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026